Obtaining drugs from foreign markets

Area of Science:

• Pharmacology
• Regulatory Science
• Patient Access to Medication

Background:

• Limited availability of novel therapeutics for institutionalized patients.
• Challenges in accessing FDA-unapproved drugs for critical care needs.
• Need for clear guidelines on drug importation processes.

Framework:

• Outlines a structured process for importing foreign drugs.
• Emphasizes prerequisite conditions: failure of traditional therapies.
• Details essential steps including regulatory applications and patient consent.

Implementation:

• Pharmacist-led coordination of drug importation.
• Navigating Investigational New Drug (IND) applications and Institutional Review Board (IRB) approvals.
• Managing logistics: customs, shipment, and documentation.

Implications:

• Expedited access to potentially life-saving foreign medications for patients.
• Ensuring patient safety through informed consent and regulatory compliance.
• Empowering pharmacists in managing complex drug access pathways.